Time to entry of generic medicines in Malaysia: implications for pharmaceutical cost containment-Reference-Cited by-同舟云学术

Time to entry of generic medicines in Malaysia: implications for pharmaceutical cost containment

Published:2013-08-06 Issue:4 Volume:4 Page:203-210
ISSN:1759-8885
Container-title:Journal of Pharmaceutical Health Services Research
language:en
Short-container-title:Journal of Pharmaceutical Health Services Research

Author:

Fatokun Omotayo¹²,Ibrahim Mohamed Izham M.³,Hassali Mohamed Azmi A.¹

Affiliation:

1. Discipline of Social and Administrative Pharmacy; School of Pharmaceutical Sciences; Universiti Sains Malaysia; Penang Malaysia

2. Faculty of Pharmaceutical Sciences; UCSI University; Kuala Lumpur Malaysia

3. College of Pharmacy; Qatar University; Doha Qatar

Publisher

Oxford University Press (OUP)

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jphs.12031/fullpdf

Reference37 articles.

1. Trade, TRIPS, and pharmaceuticals;Smith;Lancet,2009

2. Bernama Malaysia against Delays in Introducing New Generic Drugs 2011 http://iplawmalaysia.com/news/malaysia-against-delays-in-introducing-new-generic-drugs-52.html

3. World Health Organization Malaysia - national expenditure on health Geneva World Health Organization 2013 http://apps.who.int/nha/database/StandardReport.aspx?ID=REP_WEB_MINI_TEMPLATE_WEB_VERSION&COUNTRYKEY=84679

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation of cost containment strategy in pharmacy: A literature review;Journal of Advanced Pharmacy Education and Research;2023

2. An evolving role for non-governmental organizations dealing with registration backlogs and rising costs: the example of cancer biosimilars in South Africa;Generics and Biosimilars Initiative Journal;2020-03-15

3. Assessment of Policies, Determinants, and Characteristics of Generic Medicines Entry Into the Pharmaceutical Markets;Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries;2018